The company’s technology centers on a genetic-switch architecture designed to overcome the energy constraints of traditional biological nitrogen fixation. By delaying nitrogen production until microbes have successfully colonized plant roots, the platform reportedly achieves five times the nitrogen fixation levels of conventional strains. This approach aims to reduce reliance on the energy-intensive Haber-Bosch process, which currently dictates global fertilizer supply chains.
In section Releases
Switch Bioworks Gains Brazil Approval for Engineered Microbe Trials
Brazil’s National Technical Biosafety Commission has authorized Switch Bioworks to begin field testing its engineered nitrogen-fixing microbes. This regulatory clearance grants the California-based startup access to a major agricultural market, enabling a new cycle of field data collection that complements existing trials in the United States and Kenya.
Expanding into Brazil provides a critical testing ground where unique soil conditions and climate cycles challenge the technology beyond its current U.S. corn trials. As a dominant global exporter of soybeans and corn, Brazil offers both a high-volume market and an established infrastructure for biological inputs. CEO Tim Schnabel noted that this geographic expansion is essential for demonstrating the consistency of programmable microbes across diverse agricultural environments. With seven patent families protecting its core platform, Switch Bioworks is positioning its nitrogen-fixing microbes as the first application of a broader technology aimed at moving chemical manufacturing from industrial factories directly to the farm field.
Comments (0)
No comments yet. Be the first!